Edition:
United Kingdom

Axsome Therapeutics Inc (AXSM.OQ)

AXSM.OQ on NASDAQ Stock Exchange Global Market

3.22USD
5:13pm GMT
Change (% chg)

$0.27 (+9.15%)
Prev Close
$2.95
Open
$3.50
Day's High
$3.61
Day's Low
$3.19
Volume
262,739
Avg. Vol
33,973
52-wk High
$5.90
52-wk Low
$2.05

Chart for

About

Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies for the management of central nervous system (CNS) disorders, including pain. It operates in the business of developing novel therapies for the management of CNS disorders segment. Its product candidate, AXS-02... (more)

Overall

Beta: --
Market Cap(Mil.): $146.39
Shares Outstanding(Mil.): 23.61
Dividend: --
Yield (%): --

Financials

  AXSM.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -1.47 -- --
ROI: -90.07 0.28 15.02
ROE: -102.68 0.94 16.60

Earnings vs. Estimates